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ABSTRACT 26 
Heather (Calluna vulgaris) leaves contain good amounts of ursolic and oleanolic 27 
acid, which have been reported to present antiviral activity against hepatitis C virus 28 
(HCV). In this work, the supercritical fluid extraction of heather was studied with the 29 
target of assessing a potential anti-HCV activity of the extracts owing to their triterpenic 30 
acid content. Supercritical extraction assays were carried out exploring the pressure 31 
range of 20-50 MPa, temperatures of 40-70 C and 0-15% of ethanol cosolvent. The 32 
content of oleanolic and ursolic acid in the extracts were determined, and different 33 
samples were screened for cellular cytotoxicity and virus inhibition using a HCV cell 34 
culture infection system. Antiviral activity was observed in most extracts. In general, 35 
superior anti-HCV activity was observed for higher content of oleanolic and ursolic 36 
acids in the extracts. 37 
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1. INTRODUCTION 44 
For many centuries plants have been used for medicinal purposes, many have led 45 
to the discovery of important molecules such as aspirin, morphine and codeine. Heather 46 
(Calluna vulgaris L.) has been used as an herbal remedy against kidney and urinary 47 
infections as well as rheumatism. Several phytochemicals with antioxidant, anti-48 
inflammatory and anticancer activities have been identified in heather (Filip et al., 2012; 49 
Orhan et al., 2007; Saaby et al., 2009; Simon et al., 1992). Among these compounds, 50 
triterpenoids, in the form of free acids or aglycones of saponins, have gained more 51 
attention, and the number of papers describing their biological effects has increased 52 
sharply during the last decade (Banno et al., 2004; Checker et al., 2012; Ikeda et al., 53 
2008; Liu, 1995; Yan et al., 2010).  54 
Heather has also been reported to contain high concentrations of ursolic and 55 
oleanolic acid (around 40 mg/g and 10 mg/g dry matter, respectively) (Jalal et al., 1982; 56 
Zhao, 2011). Ursolic acid (3-hydroxy-urs-12-ene-28-oic acid) is a pentacyclic 57 
triterpenoid carboxylic acid which is well known because of its antioxidant, anti-58 
inflammatory, and anticancer activities, combined with a relatively low 59 
toxicity(Checker et al., 2012; Ikeda et al., 2008). Oleanolic acid (3b-hydroxyolean-12-60 
ene-28-oic acid) has been shown to have similar biological activities as ursolic acid 61 
(Liu, 1995; Yan et al., 2010). Recently, both of these compounds have been reported to 62 
have antiviral activity against hepatitis C virus (HCV) by inhibiting the NS5B RNA-63 
dependent RNA Polymerase (Kong et al., 2013). 64 
Approximately 2.8% of world population is infected with HCV (Mohd Hanafiah 65 
et al., 2013). Current standard of care treatment includes pegylated interferon alpha plus 66 
ribavirin, combined with the new directly antiviral agents (DAA) such as telaprevir, 67 
boceprevir and the recently approved polymerase inhibitor, sofosbuvir (Gilead, 2013). 68 
Most currently available anti-HCV compounds target later stages of the viral 69 
lifecyle, such as viral RNA replication, and are intended for use in chronically infected 70 
patients. Therefore, the discovery of novel compounds to block HCV cell entry is an 71 
area of intense research, with the aim of restricting universal reinfection of the donor 72 
liver by circulating virions in the setting of liver transplantation for HCV-associated end 73 
stage liver disease. The entry step of the HCV lifecycle is critical for initiation, 74 
maintenance, and dissemination of viral infection in vivo, and represents an attractive 75 
target for therapeutic intervention (Fofana et al., 2014). In the past few years, various 76 
natural compounds have been described to have direct or indirect antiviral activities 77 
against HCV (Calland et al., 2012; Lindenbach et al., 2005; Reiss et al., 2011). 78 
Supercritical fluid extraction (SFE) using carbon dioxide (CO2) is progressively 79 
replacing the organic solvent extraction, particular in the processing of natural matter. 80 
Several applications, such as the extraction of hops and the removal of caffeine from 81 
coffee beans, are well known processes performed on an industrial scale, certainly due 82 
to its advantages in comparison with conventional solid-liquid extraction. Supercritical 83 
CO2 is capable of extracting a wide range of diverse compounds, from non-polar or 84 
moderately polar compounds to more polar substances by combining CO2 with a 85 
cosolvent, such as methanol, ethanol, acetone, water, diethyl ether, among others. Yet, 86 
ethanol may be the better choice in SFE of nutraceuticals and food ingredients because 87 
of its lower toxicity.  88 
To our knowledge, the only information available concerning the supercritical 89 
CO2 extraction of heather was reported by Hunt (Hunt, 2006) and Zhao(Zhao, 2011) in 90 
their respective PhD theses developed in the University of York, UK. In these works, 91 
the extraction of the aerial part of dry plants with different harvest time was 92 
investigated, and the higher yields obtained were in the range 3.9 - 4.5 % (depending on 93 
plant harvest time) and were produced at 50C, 35 MPa and employing 10 % of ethanol 94 
as CO2 cosolvent. Ursolic acid and oleanolic acids were identified in these extracts, 95 
together with other high valued triterpenoids, such as -amyrin, -amyrin, taraxerone 96 
and taraxerol. 97 
In this work the SFE of heather was investigated in the temperature range of 40-98 
70C, pressures of 20-50 MPa and using 0-15 % ethanol cosolvent. The effect of 99 
process conditions on extraction yield and content of the triterpenic acids identified, 100 
namely ursolic acid and oleanolic acid, was evaluated. Additionally, antiviral activities 101 
of each of the extracts were tested against HCV. 102 
2. MATERIAL AND METHODS 103 
2.1 Samples and Reagents. 104 
Standards, chemicals and reagents: oleanolic acid (≥99%) and ursolic acid 105 
(≥98%) were purchased from Extrasynthese (Genay Cedex, France). Acetonitrile was 106 
HPLC grade from LabScan (Gliwice, Poland) and ethanol absolute was purchased from 107 
PANREAC (Barcelona, Spain).  108 
Heather sample consisted of dry leaves and flowers (8.4 % w/w water content) 109 
purchased from an herbalist’s producer (Murcia, Spain). The vegetal matter was ground 110 
in a cooled mill and sieved to sizes between 400 and 600 µm.    111 
2.2 Supercritical Fluid Extraction (SFE). 112 
The extractions were carried out in a pilot-plant scale supercritical fluid extractor 113 
(Thar Technology, Pittsburgh, PA, USA, model SF2000) comprising of a 2 L cylinder 114 
extraction cell with automatic control of temperature and pressure. For each experiment, 115 
the cell was filled with 0.5 kg of plant raw material. The extraction assays were 116 
performed at temperatures in the range of 40-70C and pressures of 20-50 MPa. Table 1 117 
show the conditions employed in each experiment.  118 
Extracts 11a and 11b in Table 1 were obtained by fractionation of the extract 119 
using a depressurization cascade system comprised by two separators (S1 and S2). 120 
Fractionation was accomplished by maintaining S1 at 30 MPa while S2 was set at the 121 
recirculation CO2 pressure (6 MPa). Extraction 13 was performed in two steps: the first 122 
step (Extract 13a) comprised the extraction with pure supercritical CO2 (25 MPa, 50C, 123 
1.5 h), and the second step (Extract 13b) was carried out using ethanol as co-solvent (30 124 
MPa, 50C, 2.5 h). In all other extractions the extract was collected in S1 by 125 
depressurization up to 6 MPa.  Ethanol was used to wash out the collector vessels and 126 
ensure a complete recovery of the material precipitated in the cell. Ethanol was 127 
eliminated by evaporation and the homogeneous solid samples obtained were kept at 128 
4°C in the dark until analysis.  129 
2.3 Chemical Analysis. 130 
Identification and quantification of triterpenic acids was accomplished 131 
employing a HPLC model Varian ProStar (Varian, Palo Alto, CA, USA) equipped with 132 
a Col KROMAPHASE C18 column (Scharlab, Barcelona, Spain) of 25 mm × 4.6 mm 133 
and 5 mm particle size. The analytical method used comprises of an isocratic gradient of 134 
30 min using a mixture of acetonitrile and water (90:10 % vol) as mobile phase. The 135 
flow rate was constant at 1 mL/min and the injection volume was 20 μL. The detection 136 
of compounds was carried out at a wavelength of 210 nm. The quantification of 137 
triterpenic acids was accomplished by calibration curves with commercial standards of 138 
ursolic, oleanolic and betulinic acids; straight lines were obtained with linear 139 
regressions higher than 0.999. 140 
2.4 Cells, Virus, Extract Dilutions.  141 
Huh7.5 cells were grown in complete Dulbecco’s modification of Eagle’s 142 
medium (DMEM) (Invitrogen) with 10% fetal calf serum (FCS), as previously 143 
described in Perales et al (Perales et al., 2013). The HCV cell culture (HCVcc) virus 144 
derived from the plasmid, Jc1FLAG2(p7-nsGluc2A) or the monocistronic luciferase 145 
reporter virus JcR2a were used to infect Huh7.5 cells, a viral stocks had been previously 146 
generated as described (Perales et al., 2013; Reiss et al., 2011).  147 
Supercritical heather extractions, oleanolic acid and ursolic acid were diluted in 148 
absolute ethanol to 50 mg/ml and stored at -80ºC, for further dilutions, the extracts were 149 
diluted in complete DMEM (Fan et al., 2011). 150 
2.5 Cytotoxicity.  151 
To test for cytotoxicity Huh7.5 cells were plated to semiconfluency and 152 
incubated at 37°C, 5% CO2 with each extract in 5-fold dilutions at concentrations 0, 153 
0.64, 3.2, 16, 80, 400, 2,000 and 10,000 g/ml. After 48 hours, MTT [3-(4,5-154 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma) was added to each 155 
well at a final concentration of 500 g/ml and incubated for a further 3 hours, the media 156 
was then removed and 100 l of dimethyl sulfoxide (DMSO) (Sigma) was added to 157 
each well, the optical density was measured at a wavelength of 550 nm. The 50% 158 
cytotoxicity concentration (CC50) was then calculated using the optical density 159 
percentage compared to untreated cells. Standard deviations were calculated from 4 160 
replicates. 161 
2.6 HCV inhibition assay.  162 
Huh7.5 cells were plated in 96-well plates to semiconfluency (6.4x103 per well) 163 
and infected with  tissue culture infective dose (TCID) of 192 (approximately MOI 164 
0.03) of HCVcc, 5 hours later, each extract was added to the wells in 2-fold dilutions at 165 
concentrations 0, 6.25, 12.5, 25, 50, 100, 200 and 400g/ml and incubated for 48 hours. 166 
The cells were then washed with PBS, fixed with methanol and stained for HCV NS5A 167 
antibodies (Lindenbach et al., 2005). Foci forming units were counted and compared to 168 
wells without extract. Percentages were used to calculate HCV inhibition. Standard 169 
deviations were calculated from 4 replicates.  170 
For the HCV entry assay, a monocistronic luciferase reporter virus JcR2a was 171 
used(Anggakusuma et al., 2013). Huh7.5 cells were inoculated with JcR2a virus in the 172 
presence of increasing concentration of the extracts. The green tea molecule 173 
Epigallocatechin-3-gallate (EGCG) was used as positive control(Ciesek et al., 2011). 174 
The inoculum was removed 4 h later and then monolayers were washed and overlaid 175 
with fresh medium containing no inhibitors. Infected cells were lysed 3 days later and 176 
Renilla luciferase activity was determined as described(Ciesek et al., 2011).  177 
 178 
3 RESULTS  179 
3.1 Extraction Yield and Recovery of Triterpenic Acids.  180 
The extraction yield (g extract / g heather) obtained in the different experiments 181 
are given in Table 1. Extraction 9 was carried out at similar extraction conditions than 182 
those employed by Zhao (2011)(Zhao, 2011) and similar yields were obtained. 183 
Figure 1 shows the variation of extraction yield with temperature (Figure 1a), 184 
pressure (Figure 1b) and amount of ethanol cosolvent (Figure 1c). As observed, the 185 
most significant effect on extraction yield is produced by the addition of ethanol as 186 
cosolvent of the supercritical CO2 solvent. With respect to pure CO2, around a 4-fold 187 
increase (from 2.16 to 7.31 %) of yield is produced when using ethanol as CO2 188 
cosolvent.  189 
Additionally, the increase of extraction temperature from 40C to 60C favors 190 
the recovery of phytochemicals from heather, but a further increase of temperature has 191 
the opposite effect.  192 
Extractions 4 and 11 in Table 1 were obtained using the same extraction 193 
temperature and pressure, but slightly higher CO2/plant ratio in extraction 4 (24 kg/kg 194 
vs 21.6 kg/kg) and also slightly higher extraction yield was obtained (2.45 vs 2.20 %). 195 
Nevertheless, fractionation of the extract in extraction 11 produced two samples with 196 
noticeably different yields: extraction 11a (0.26 % yield, S1 separator) and extraction 197 
11b (1.94 % yield, S2 separator).  198 
Alternatively, extraction 13 was carried out in two steps, using different 199 
extraction conditions in each step. Comparing both steps it can be clearly deduced the 200 
key effect of ethanol as CO2 cosolvent, since 5.28 % yield was obtained in the second 201 
step when 2.65 % of phytochemicals were already extracted in the first step.   202 
The concentration (mg acid / g extract) of ursolic and oleanolic determined by 203 
HPLC in all supercritical extracts produced is shown in Table 2. The higher 204 
concentrations of the triterpenic acids were obtained when at least 10 % ethanol was 205 
employed as cosolvent (Extracts 9, 10, 12 and 13b) with values in the range of 90-220 206 
mg triterpenic acids / g extract (1.1-2.3 % w/w). In all other experiments no ethanol was 207 
employed, and triterpenic acids were present in concentrations lower than 30 mg/g, but 208 
as a result of the on-line fractionation procedure, 116 mg/g of triterpenic acids was 209 
obtained in the first fraction of extraction 11 (Ext. 11a) without using ethanol, although 210 
very low extraction yield was achieved in this fraction (0.26 %).   211 
The highest concentration of triterpenic acids was obtained in extract 10 (82.87 212 
mg/g of oleanolic acid and 141.45 mg/g of ursolic acid) which was produced at 213 
moderate pressure (30 MPa) and with the higher ethanol content utilized in this work 214 
(15 %). Taking into account the concentration of these triterpenic acids in the dry matter 215 
reported in the literature(Jalal et al., 1982; Zhao, 2011), this represents a 3.5 and 8.3 216 
fold increase for, respectively, ursolic and oleanolic acid. Furthermore, this extraction 217 
was the one with the higher yield (7.31 %).  218 
Additionally, it could be observed from Table 2 that the ratio of oleanolic acid / 219 
ursolic acid resulted in values considerably lower than 1 (from 0.14 to 0.43), in the case 220 
of extractions with pure CO2. Unfortunately, no solubility data was found in the 221 
literature to support this observed behavior. Nevertheless, this seems to be a reasonable 222 
tendency, since ursolic acid is present in heather in higher concentrations than oleanolic 223 
acid (oleanolic acid / ursolic acid ratio in heather  0.25). On the contrary, when ethanol 224 
is utilized, this ratio becomes very close or greater than 1 and higher concentrations of 225 
oleanolic acid with respect to ursolic acid were obtained (oleanolic acid / ursolic acid 226 
ratio up to 1.42 in extraction 13b). This result could be related to the higher solubility of 227 
oleanolic acid in ethanol in comparison with ursolic acid solubility(Fan et al., 2011), 228 
and is showing a great effect of ethanol as cosolvent in the supercritical extraction, 229 
tuning selectivity towards the extraction of oleanolic acid.  230 
3.2 Anti-HCV Activity of the Extracts.  231 
Previously, Kong et al(Kong et al., 2013) reported that oleanolic and ursolic acid 232 
were able to inhibit the HCV polymerase activity. Considering the high content of 233 
oleanolic and ursolic acids found in heather, the anti-HCV activity of heather 234 
supercritical extracts produced in this work was evaluated and compared. 235 
All 15 extracts with different contents of oleanolic and ursolic acid, were 236 
screened for cellular cytotoxicity and HCV inhibition using the HCV cell culture system 237 
(see materials and methods). Moreover, both oleanolic and ursolic compounds were also 238 
tested in parallel as controls.  239 
The system uses a full length HCV infectious clone that is able to undergo the 240 
complete replication cycle in vitro. Cytotoxicity was observed in all extracts at 241 
concentrations more than 200 µg/ml and in most extracts at 100 µg/mg. Nevertheless, in 242 
all cases there was reduction in the viral infectivity in a dose dependent manner at 243 
concentrations where cytotoxicity was not observed. In particular, extracts  9 and 13b 244 
showed more striking reductions in their infectivity, which coincided with higher levels 245 
of oleanolic and ursolic acid (see Figure 2A and Table 2).  246 
 To investigate specifically the early steps (viral entry) of the viral life cycle, a 247 
luciferase reporter HCV was used. Human hepatoma cells were incubated for 4 hours in 248 
the presence of the extracts and virus before washing and replacing with fresh media 249 
(Figure 2B). The green tea molecule Epigallocatechin-3-gallate (EGCG) was used as 250 
positive control, as we have previously shown that ECGC inhibits HCV infectivity by 251 
blocking the virus entry process(Ciesek et al., 2011). No cytotoxicity was observed at 252 
concentrations of 125 µg/ml or less. All extracts showed some inhibition in the HCV 253 
infectivity in a dose-dependent manner and 6/15 inhibited at least 50% HCV entry. 254 
Again high connection was observed with the inhibition of HCV entry and the 255 
concentration of oleanolic and ursolic acid.  256 
To determine whether there was a correlation between the concentration of 257 
oleanolic acid or ursolic acid and HCV inhibition, infectivity (% of negative control) 258 
was represented as a function of the actual amount of oleanolic or ursolic acid utilized 259 
in the assays, and calculated as the concentration of each compound for each extract 260 
dilution used in the viral entry assay or the complete replication assay. These results are 261 
depicted in Figure 3; only extracts which do not exhibit cytotoxicity were included in 262 
the representation. As can be observed in Figure 3 a certain dependence of the antiviral 263 
effect can be attributed to the presence of both ursolic and oleanolic acids, suggesting 264 
both these compounds may have anti-HCV properties. Oleanolic and ursolic acid 265 
concentrations correlated more with inhibition of viral entry (Figures 3A and C) (R
2
= 266 
0.7948 and 0.3732 respectively) compared to the inhibition of the full viral lifecycle 267 
(Figures 3B and C) (oleanolic acid R
2
= 0.2598 and ursolic acid R
2
= 0.0821). 268 
 269 
4 CONCLUSIONS.  270 
Supercritical fluid extraction produced heather extracts with high concentration 271 
of triterpenic (oleanolic and ursolic) acids. In this respect, the use of ethanol as 272 
cosolvent was crucial. Concentrations up to 80 mg/g of oleanolic acid and 140 mg/g of 273 
ursolic acid were attained using 15% ethanol cosolvent, which are significantly higher 274 
than those obtained without cosolvent (2-12 mg/g of oleanolic acid and 10-20 mg/g of 275 
ursolic acid) despite the extraction pressure (20-50 MPa) or temperature (40-70 C) 276 
applied. Furthermore, the use of ethanol as cosolvent turned the selectivity of the 277 
supercritical solvent to favor the extraction of oleanolic acid, despite the lower amount 278 
of this triterpenic acid in the vegetal raw matter.  279 
The extracts showed antiviral activity in a complete life cycle assay for HCV 280 
and interestingly also when only presented during viral entry. The extracts with higher 281 
concentration of ursolic and oleanolic acid showed higher inhibition, and certain 282 
dependence of the anti-HCV activity and the presence of ursolic and oleanolic acid in 283 
the extracts was observed. Further studies are required to elucidate the mode of action 284 
against that human important virus.  285 
 286 
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  364 
  365 
Table 1. SFE conditions and yields obtained in the extraction of heather leaves. 366 
Extract Pressure Temperature Time CO2 flow Co-solvent Yield 
  (MPa) (ºC) (h) (g/ min) (% ethanol) (%) 
1  20 50 3 60 0 1.17 
2  30 50 3 60 0 2.16 
3  40 50 3 60 0 2.32 
4  50 50 3 60 0 2.45 
5  40 40 3 60 0 2.04 
6  40 60 3 60 0 3.35 
7  40 70 3 60 0 2.40 
8  30 50 3 60 5 3.66 
9  30 50 3 60 10 4.68 
10  30 50 3 60 15 7.31 
11a S1 50 50 4 50 0 0.26 
11b S2      1.94 
12  30 50 4 50 10 1.71 
13a  First step 25 50 1.5 50 0 2.65 
13b   Second step 30 50 2.5 50 10 5.28 
  367 
  368 
Table 2. Content of triterpenic acids identified in heather SFE extracts. 369 
Extract Oleanolic acid Ursolic acid 
  (mg/g extract) (mg/g extract) 
1  0.53 16.02 
2  2.36 16.92 
3  3.55 15.49 
4  5.66 18.86 
5  2.49 17.85 
6  5.90 14.31 
7  9.19 21.59 
8  12.41 11.33 
9  69.75 55.57 
10  82.87 141.45 
11 S1 13.50 98.56 
 S2 2.53 2.95 
12  54.04 38.67 
13 First step 1.44 2.19 
 Second step 73.14 51.62 
  370 
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FIGURE LEGENDS 372 
 373 
Figure 1. Extraction yields of heather SFE as a function of (a) extraction 374 
pressure (50C, no cosolvent), (b) extraction temperature (40 MPa, no cosolvent) and  375 
(c) ethanol cosolvent added to supercritical CO2 (50C and 30 MPa). Solid lines: 376 
experimental trend.  377 
 378 
Figure 2. Anti-HCV activity of Heather extracts. (A) Huh7.5 cells were infected 379 
with HCVcc at a MOI of 0.03, 5 hours later; each extract was added to the wells in 2-380 
fold dilutions at concentrations 0, 6.25, 12.5, 25, 50, 100g/ml and incubated for 48 381 
hours. The cells stained for HCV NS5A antibodies and foci forming units were counted 382 
and compared to wells without extract (see materials and methods). Percentages were 383 
used to calculate HCV inhibition. Standard deviations were calculated from 4 replicates. 384 
(*) indicate when cytotoxicity was observed. (B) Huh7.5 cells were inoculated with 385 
HCV (JcR2a virus) in the presence of increasing concentration of the extracts. The 386 
green tea molecule Epigallocatechin-3-gallate (EGCG) was used as positive control 387 
[23]. The inoculum was removed 4 h later and then monolayers were washed and 388 
overlaid with fresh medium containing no inhibitors. Infected cells were lysed 3 days 389 
later and Renilla luciferase activity was determined as described [23].  390 
 391 
Figure 3. Anti-HCV activity of Oleanolic and Ursolic acids. Concentrations of 392 
oleanolic acid (3A, 3B) or ursolic acid (3C, 3D) are plotted against HCV inhibition, for 393 
either the 4 h entry assay (3A, 3C) or 48 h full lifecycle assays (3B, 3D). Linear 394 
regression analyses are represented in the box at the top right corner of each graph. 395 
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